Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus
1 other identifier
observational
247
1 country
1
Brief Summary
Background Gestational diabetes mellitus (GDM) is a condition that can have negative impacts on both mother and baby. Detecting GDM early is crucial, and fasting plasma glucose (FPG) has been suggested as a possible screening method. This retrospective cross-sectional study aims to investigate potential risk factors and complications associated with GDM. Additionally, it aims to establish the diagnostic performance of predictive factors as a screening method for GDM. Methods Data were collected from the medical records of 247 pregnant women who visited high-risk pregnancy outpatient clinics at King Abdul-Aziz Medical City in Jeddah between 2021 and 2022. The study investigated potential risk factors and complications associated with gestational diabetes mellitus (GDM), including impaired fasting glucose/impaired glucose tolerance (IFG/IGT), family history of diabetes mellitus (DM), and medical conditions. Moreover, the study evaluated the diagnostic performance of potential predictors as screening techniques for gestational diabetes mellitus (GDM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2023
CompletedFirst Submitted
Initial submission to the registry
October 15, 2023
CompletedFirst Posted
Study publicly available on registry
October 31, 2023
CompletedOctober 31, 2023
October 1, 2023
11 months
October 15, 2023
October 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Complications associated with gestational diabetes mellitus
The study investigated potential risk factors and complications associated with gestational diabetes mellitus (GDM), including impaired fasting glucose/impaired glucose tolerance (IFG/IGT), family history of diabetes mellitus (DM), and medical conditions.
1 year
Interventions
Pregnant patient who visited obstetric clinic , who did 75 g glucose tolerance test
Eligibility Criteria
All pregnant patients who attend high risk pregnancy outpatient's clinic at national guard hospital in Jeddah during 2021-2022. Dependent Variable: OGTT - Fasting Blood Glucose - Weight - Pregestational BMI Independent Variable(s): Age, Gender, Medication, Gestational age, Chronic diseases, Family history, Past gyne and medical history.
You may qualify if:
- Singleton pregnant women who received prenatal care services in Obstetrics clinics at king Abdul-Aziz medical city.
You may not qualify if:
- Pregnant known to have diabetes mellitus.
- Participant with Autoimmune disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatimah Khobrani
Jeddah, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fatimah M Khobrani, Associate
KAMC
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate consultant family medicine
Study Record Dates
First Submitted
October 15, 2023
First Posted
October 31, 2023
Study Start
May 23, 2022
Primary Completion
May 1, 2023
Study Completion
July 2, 2023
Last Updated
October 31, 2023
Record last verified: 2023-10